Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

LHCAX vs. PRHSX: which is better?

Bottom line

LHCAX vs PRHSX: the short answer

LHCAX (Lord Abbett Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.

But PRHSX is far broader, holding 279 positions to 61 for LHCAX, so beyond the top names it adds exposure LHCAX doesn't have.

PRHSX is cheaper at 0.83% vs 1.03% — a difference of $20 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +3.1% for LHCAX.

LHCAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

LHCAX vs PRHSX side by side

LHCAXPRHSX
TypeMutual fundMutual fund
Fund familyLord AbbettT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.03%0.83%
Annual cost per $10k$103$83
10-yr cost on $10k (prospectus)$3,961$1,025
Max front load5.75%—
12b-1 fee0.25%—
1-yr return+10.9%+17.7%
5-yr return (annualized)+3.1%+4.2%
10-yr return (annualized)—+9.1%
Best quarter+21.5%+23.5%
Worst quarter−11.4%−15.8%
Net assets (fund)$8.6M$11.9B
Number of holdings61279
Portfolio turnover91%62%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearLHCAXPRHSXDifference
2025+17.7%+17.7%−0.1%
2024+7.3%+1.8%+5.5%
2023+2.9%+3.1%−0.2%
2022−12.0%−12.2%+0.2%
2021+8.2%+13.3%−5.0%
2020+37.1%+30.1%+7.0%

Source: Fund prospectus bar charts

Holdings overlap

10 of LHCAX's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingLHCAXPRHSX
Eli Lilly & Co10.40%14.28%
UnitedHealth Group Inc5.39%5.99%
Johnson & Johnson4.96%6.63%
Natera Inc3.60%1.44%
Gilead Sciences Inc3.53%2.82%
CVS Health Corp3.33%0.94%
Guardant Health Inc2.61%1.23%
Thermo Fisher Scientific Inc2.31%2.52%
Vertex Pharmaceuticals Inc2.24%2.28%
Protagonist Therapeutics Inc1.44%0.85%

Source: SEC Form N-PORT

LHCAX top 10

  1. Eli Lilly & Co — 10.40%
  2. UnitedHealth Group Inc — 5.39%
  3. Johnson & Johnson — 4.96%
  4. Novartis AG — 4.19%
  5. Natera Inc — 3.60%
  6. Gilead Sciences Inc — 3.53%
  7. CVS Health Corp — 3.33%
  8. Guardant Health Inc — 2.61%
  9. Galderma Group AG — 2.60%
  10. Thermo Fisher Scientific Inc — 2.31%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between LHCAX and PRHSX?
LHCAX (Lord Abbett Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. But PRHSX is far broader, holding 279 positions to 61 for LHCAX, so beyond the top names it adds exposure LHCAX doesn't have.
Which is cheaper, LHCAX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both LHCAX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.